InvestorsObserver
×
News Home

Where Will Johnson & Johnson (JNJ) Stock Go Next After It Has Fallen 0.86% in a Week?

Thursday, June 30, 2022 02:28 PM | InvestorsObserver Analysts

Mentioned in this article

Where Will Johnson & Johnson (JNJ) Stock Go Next After It Has Fallen 0.86% in a Week?

Overall market sentiment has been down on Johnson & Johnson (JNJ) stock lately. JNJ receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
Johnson & Johnson has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on JNJ!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With JNJ Stock Today?

Johnson & Johnson (JNJ) stock is trading at $178.11 as of 2:19 PM on Thursday, Jun 30, a rise of $1.13, or 0.64% from the previous closing price of $176.98. Volume today is less active than usual. So far 5,387,513 shares have traded compared to average volume of 7,548,974 shares. The stock has traded between $175.03 and $178.25 so far today. To see InvestorsObserver's Sentiment Score for Johnson & Johnson click here.

More About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States. Click Here to get the full Stock Report for Johnson & Johnson stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App